Oncology Pharmacovigilance Director

GSK; Upper Providence (Delaware County); Hybrid; USD 170,000 - 283,000; Full time

Benefits offered by this job

Health care benefits

Retirement benefits

Paid holidays

Paid leave

Job summary

GSK is seeking a Senior Pharmacovigilance Scientist for a hybrid U.S. position. You will lead safety governance and risk management for the portfolio, supporting global regulatory submissions and post-marketing activities.

The role requires deep PV expertise, cross-functional leadership, and strong communication with regulatory authorities. Based in the United States with remote-work balance, you will influence safety strategy and drive process improvements across SERM processes for oncology,

Qualifications

• PhD or PharmD preferred with strong pharmacovigilance background.
• Experience in drug safety, risk management and regulatory interactions.
• Knowledge of international pharmacovigilance requirements (ICH, GVP) and clinical development.

Responsibilities

• Leads PV and risk management planning and safety strategy for products.
• Supports safety reviews for global regulatory submissions and post-marketing.
• Interacts with regulatory authorities and cross-functional teams on safety.
• Drives process improvements and safety governance across SERM activities.
• Mentors team members and communicates safety issues to senior stakeholders.

Skills

Digital Fluency

Enterprise Leadership

Influencing Without Authority

Pharmacovigilance

Presentation Techniques

Education

PhD or PharmD

BS in life sciences

Job description

GSK is seeking a Senior Pharmacovigilance Scientist for a hybrid U.S. position. You will lead safety governance and risk management for the portfolio, supporting global regulatory submissions and post-marketing activities.

The role requires deep PV expertise, cross-functional leadership, and strong communication with regulatory authorities. Based in the United States with remote-work balance, you will influence safety strategy and drive process improvements across SERM processes for oncology,